1. PHARMAC’s principal objective is “to secure for eligible people in need of pharmaceuticals the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided”. Section 47(a) of the New Zealand Public Health and Disability Act 2000 (NZPHD Act). http://www.legislation.govt.nz/act/public/2000/0091/latest/DLM80878.html [accessed 14.07.16]
2. Access to new medicines in New Zealand compared to Australia;Wonder;N Z Med J,2011
3. Do pharmaceutical score cards give us the answers we seek?;Moodie;N Z Med J,2011
4. Response to PHARMAC on access to new medicines in New Zealand compared to Australia;Wonder;N Z Med J,2011
5. Comparison of access and reimbursement environments;Medicines Australia;A report benchmarking Australia’s access to new medicines,2015